Home > News

 

 

ARCHIVE NEWS
A behavioral therapy app to close the access gap in COPD treatment
18 April 2023
World Health Day: our commitment to provide Health For All
07 April 2023
European Parliament vote on the revision of the EU’s legislative framework on F-gas: climate targets need innovative solutions
03 April 2023
In 2022 Chiesi Group has been confirmed as the 1st Italian pharmaceutical company for the number of patents filed
28 March 2023
What does it mean to be a B Corp? Chiesi's choice for a sustainable future
01 March 2023
Rare Disease Day
28 February 2023
Chiesi Group stands in solidarity with the people of #Turkiye and #Syria
09 February 2023
The Chiesi Group and gender equality: a concrete achievement now certified by Bureau Veritas
10 February 2023
The Alphabet of Sustainability
01 February 2023
Discovering ESG Criterias (Environmental, Social and Governance), the Chiesi Group's committment
17 January 2023
© 2025 CHIESI Farmaceutici S.p.A.
VAT IT 01513360345
Company's Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271

PHARMACOVIGILANCE

TO REPORT ADVERSE DRUG EVENTS/REACTIONS PLEASE CLICK HERE


follow us on: